{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:34:09Z","timestamp":1791945249288,"version":"4.3.4"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSTC 112\\u20132124-M-038\\u2013001"],"award-info":[{"award-number":["NSTC 112\\u20132124-M-038\\u2013001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSTC 113\\u20132124-M-038\\u2013003"],"award-info":[{"award-number":["NSTC 113\\u20132124-M-038\\u2013003"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["111\\u20132124-M-038\\u2013001"],"award-info":[{"award-number":["111\\u20132124-M-038\\u2013001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejps.2025.107398","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T08:08:06Z","timestamp":1764922086000},"page":"107398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Dual-functionalized mesoporous silica nanoparticles for topical axitinib delivery to the posterior eye segment"],"prefix":"10.1016","volume":"217","author":[{"given":"Li","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1578-551X","authenticated-orcid":false,"given":"Zih-An","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7085-9053","authenticated-orcid":false,"given":"Cheng-Hsun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5443-2632","authenticated-orcid":false,"given":"Yi-Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2586-7538","authenticated-orcid":false,"given":"Si-Han","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Yuan","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9446-4030","authenticated-orcid":false,"given":"Ching-Li","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueh","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardy Wai-Hong","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3078-8276","authenticated-orcid":false,"given":"Tien-Chun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Hwa","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2025.107398_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14071444","article-title":"Retinal delivery of the protein Kinase C-\u03b2 inhibitor ruboxistaurin using non-invasive nanoparticles of polyamidoamine dendrimers","volume":"14","author":"Alshammari","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107398_bib0002","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0002-9394(00)00961-2","article-title":"Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation","volume":"131","author":"Anderson","year":"2001","journal-title":"Am. J. Ophthalmol"},{"key":"10.1016\/j.ejps.2025.107398_bib0003","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1002\/smll.201301004","article-title":"Uptake kinetics and nanotoxicity of silica nanoparticles are cell type dependent","volume":"9","author":"Blechinger","year":"2013","journal-title":"Small."},{"key":"10.1016\/j.ejps.2025.107398_bib0004","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bjophthalmol-2013-304033","article-title":"Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010","volume":"98","author":"Bourne","year":"2014","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejps.2025.107398_bib0005","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1743-8977-11-18","article-title":"Physicochemical characteristics of nanomaterials that affect pulmonary inflammation","volume":"11","author":"Braakhuis","year":"2014","journal-title":"Part Fibre Toxicol."},{"key":"10.1016\/j.ejps.2025.107398_bib0006","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1469-7580.2005.00389.x","article-title":"The human choriocapillaris: evidence for an intrinsic regulation of the endothelium?","volume":"206","author":"Cavallotti","year":"2005","journal-title":"J. Anat."},{"key":"10.1016\/j.ejps.2025.107398_bib0007","article-title":"Tacrolimus loaded cationic liposomes for dry eye treatment","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107398_bib0008","doi-asserted-by":"crossref","first-page":"12716","DOI":"10.1021\/acsnano.3c08993","article-title":"Receptor ligand-free mesoporous silica nanoparticles: a streamlined strategy for targeted drug delivery across the blood\u2013brain barrier","volume":"18","author":"Chen","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejps.2025.107398_bib0009","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1021\/acsami.8b18434","article-title":"Critical features for mesoporous silica nanoparticles encapsulated into erythrocytes","volume":"11","author":"Chen","year":"2019","journal-title":"ACS. Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejps.2025.107398_bib0010","doi-asserted-by":"crossref","first-page":"15322","DOI":"10.1021\/acsami.9b02797","article-title":"Codelivery of plasmid and curcumin with mesoporous silica nanoparticles for promoting neurite outgrowth","volume":"11","author":"Cheng","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejps.2025.107398_bib0011","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"Del Amo","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejps.2025.107398_bib0012","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1021\/acsami.2c17544","article-title":"Overcoming cytosolic delivery barriers of proteins using denatured protein-conjugated mesoporous silica nanoparticles","volume":"15","author":"Demb\u00e9l\u00e9","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejps.2025.107398_bib0013","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.gendis.2021.02.009","article-title":"Age-related macular degeneration: epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy","volume":"9","author":"Deng","year":"2022","journal-title":"Genes. Dis."},{"key":"10.1016\/j.ejps.2025.107398_bib0014","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jcp.21426","article-title":"Topical administration of a multi-targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema","volume":"216","author":"Doukas","year":"2008","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.ejps.2025.107398_bib0015","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jconrel.2024.07.022","article-title":"ROS-responsive charge reversal mesoporous silica nanoparticles as promising drug delivery system for neovascular retinal diseases","volume":"373","author":"Elbedwehy","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2025.107398_bib0016","first-page":"617","article-title":"A stepwise optimization strategy to formulate in situ gelling formulations comprising fluconazole-hydroxypropyl-beta-cyclodextrin complex loaded niosomal vesicles and eudragit nanoparticles for enhanced antifungal activity and prolonged ocular delivery","volume":"15","author":"Elmotasem","year":"2020","journal-title":"Asian J. Pharm. Sci."},{"issue":"Suppl 6","key":"10.1016\/j.ejps.2025.107398_bib0017","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.5301\/EJO.2010.6051","article-title":"Drug delivery to the posterior segment of the eye","volume":"21","author":"Fischer","year":"2011","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.ejps.2025.107398_bib0018","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1096\/fj.13-235440","article-title":"Unexpected low-dose toxicity of the universal solvent DMSO","volume":"28","author":"Galvao","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.ejps.2025.107398_bib0019","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1167\/iovs.10-6266","article-title":"In vivo evaluation of laser-induced choroidal neovascularization using spectral-domain optical coherence tomography","volume":"52","author":"Giani","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejps.2025.107398_bib0020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.exer.2016.02.010","article-title":"Axitinib inhibits retinal and choroidal neovascularization in in vitro and in vivo models","volume":"145","author":"Giddabasappa","year":"2016","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejps.2025.107398_bib0021","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1021\/acs.molpharmaceut.8b01136","article-title":"Multifunctional nanocomposites based on liposomes and layered double hydroxides conjugated with glycylsarcosine for efficient topical drug delivery to the posterior segment of the eye","volume":"16","author":"Gu","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2025.107398_bib0022","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/09286586.2022.2059812","article-title":"A systematic review of clinical practice guidelines for age-related macular degeneration","volume":"30","author":"Han","year":"2023","journal-title":"Ophthalmic. Epidemiol."},{"key":"10.1016\/j.ejps.2025.107398_bib0023","doi-asserted-by":"crossref","first-page":"7272","DOI":"10.1158\/1078-0432.CCR-08-0652","article-title":"Nonclinical antiangiogenesis and antitumor activities of Axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3","volume":"14","author":"Hu-Lowe","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejps.2025.107398_bib0024","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jconrel.2022.05.009","article-title":"Penetrating-peptide-mediated non-invasive Axitinib delivery for anti-neovascularisation","volume":"347","author":"Huang","year":"2022","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2025.107398_bib0025","doi-asserted-by":"crossref","unstructured":"Israilevich, R., Mahmoudzadeh, R., Salabati, M., 2021. Narrative review-drug delivery in age-related macular degeneration.","DOI":"10.21037\/aes-21-8"},{"key":"10.1016\/j.ejps.2025.107398_bib0026","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0165-0270(95)00015-M","article-title":"An ex vivo rat retinal preparation for excitotoxicity studies","volume":"60","author":"Izumi","year":"1995","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejps.2025.107398_bib0027","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/aos.14177","article-title":"Thirteen years of intravitreal anti-vascular endothelial growth factor therapy: the promises and burdens of a paradigm shift told from the perspective of the largest retina service in Norway","volume":"98","author":"J\u00f8rstad","year":"2020","journal-title":"Acta Ophthalmol. (Copenh)"},{"key":"10.1016\/j.ejps.2025.107398_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124018","article-title":"Drug-like properties of tyrosine kinase inhibitors in ophthalmology: formulation and topical availability","volume":"655","author":"Jansook","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107398_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.155073","article-title":"Cyclic RGD conjugated PEG-PLGA nanoparticle enhances preventative effect of bilirubin on the development of ultraviolet-B (UVB)-induced cataract","volume":"497","author":"Jin","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.ejps.2025.107398_bib0030","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.nano.2015.04.015","article-title":"Size, surface charge, and shape determine therapeutic effects of nanoparticles on brain and retinal diseases","volume":"11","author":"Jo","year":"2015","journal-title":"Nanomed.: Nanotechnol. Biol. Med."},{"key":"10.1016\/j.ejps.2025.107398_bib0031","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1080\/17425247.2025.2516668","article-title":"Tyrosine kinase inhibitors and their promising role in treating diabetic retinopathy and other retinal vascular diseases: overview of their routes of administration, pharmacokinetics, formulations, and drug delivery applications","volume":"22","author":"Kadavil","year":"2025","journal-title":"Expert. Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2025.107398_bib0032","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3390\/ph14050480","article-title":"Bio-distribution and pharmacokinetics of topically administered \u03b3-cyclodextrin based eye drops in rabbits","volume":"14","author":"Kallab","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejps.2025.107398_bib0033","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12967-023-03937-7","article-title":"Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration","volume":"21","author":"Khachigian","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejps.2025.107398_bib0034","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11095-008-9745-6","article-title":"Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina","volume":"26","author":"Kim","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107398_bib0035","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/pharmaceutics14010134","article-title":"Topical drug delivery to the posterior segment of the eye","volume":"14","author":"L\u00f6scher","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107398_bib0036","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejps.2014.04.018","article-title":"Topical drug delivery to retinal pigment epithelium with microfluidizer produced small liposomes","volume":"62","author":"Lajunen","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107398_bib0037","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/nprot.2013.135","article-title":"Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice","volume":"8","author":"Lambert","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejps.2025.107398_bib0038","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1167\/iovs.02-1179","article-title":"Dose-dependent modulation of choroidal neovascularization by plasminogen activator inhibitor type I: implications for clinical trials","volume":"44","author":"Lambert","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejps.2025.107398_bib0039","doi-asserted-by":"crossref","first-page":"61787","DOI":"10.1021\/acsami.4c16609","article-title":"Drug-free mesoporous silica nanoparticles enable suppression of cancer metastasis and confer survival advantages to mice with tumor xenografts","volume":"16","author":"Lee","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejps.2025.107398_bib0040","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1021\/acs.molpharmaceut.0c00224","article-title":"Nanoparticulate drug delivery to the retina","volume":"18","author":"Li","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2025.107398_bib0041","article-title":"Overview of recent advances in nano-based ocular drug delivery","volume":"24","author":"Liu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2025.107398_bib0042","article-title":"Topical dexamethasone delivery to the retina: an aqueous cyclodextrin-based microsuspension","volume":"81","author":"Loftsson","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2025.107398_bib0043","first-page":"65","article-title":"Mesoporous silica nanoparticles in nanomedicine applications","volume":"29","author":"Manzano","year":"2018","journal-title":"J. Mater. Sci.: Mater. Med."},{"key":"10.1016\/j.ejps.2025.107398_bib0044","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.drudis.2019.05.006","article-title":"Therapeutic implications of nanomedicine for ocular drug delivery","volume":"24","author":"Meng","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2025.107398_bib0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/adt.2019.920","article-title":"Axitinib-loaded poly (lactic-co-glycolic acid) nanoparticles for age-related macular degeneration: formulation development and in vitro characterization","volume":"17","author":"Narvekar","year":"2019","journal-title":"Assay. Drug Dev. Technol."},{"key":"10.1016\/j.ejps.2025.107398_bib0046","series-title":"Future of Mesoporous Silica Nanoparticles in nanomedicine: Protocol For Reproducible synthesis, characterization, Lipid coating, and Loading of Therapeutics (chemotherapeutic, proteins, siRNA and mRNA)","author":"Noureddine","year":"2023"},{"key":"10.1016\/j.ejps.2025.107398_bib0047","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s11596-020-2253-6","article-title":"Recent developments in the treatment of wet age-related macular degeneration","volume":"40","author":"Papadopoulos","year":"2020","journal-title":"Curr. Med. Sci."},{"key":"10.1016\/j.ejps.2025.107398_bib0048","article-title":"Recent advances in drug delivery systems for glaucoma treatment","volume":"18","author":"Patel","year":"2022","journal-title":"Mater. Today Nano"},{"key":"10.1016\/j.ejps.2025.107398_bib0049","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.3390\/molecules26154673","article-title":"Lipid nanoparticles traverse non-corneal path to reach the posterior eye segment: in vivo evidence","volume":"26","author":"Puglia","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2025.107398_bib0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejps.2018.03.034","article-title":"Corneal and conjunctival drug permeability: systematic comparison and pharmacokinetic impact in the eye","volume":"119","author":"Ramsay","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107398_bib0051","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11092445","article-title":"Neovascular progression and retinal dysfunction in the laser-induced choroidal neovascularization mouse model","volume":"11","author":"Salas","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejps.2025.107398_bib0052","article-title":"The utility and risks of therapeutic nanotechnology in the retina","volume":"13","author":"Scheive","year":"2021","journal-title":"Ther. Adv. Ophthalmol."},{"key":"10.1016\/j.ejps.2025.107398_bib0053","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.4.3.11","article-title":"Topical ocular drug delivery to the back of the eye by mucus-penetrating particles","volume":"4","author":"Schopf","year":"2015","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.ejps.2025.107398_bib0054","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41433-020-0770-y","article-title":"Use of biomaterials for sustained delivery of anti-VEGF to treat retinal diseases","volume":"34","author":"Seah","year":"2020","journal-title":"Eye"},{"key":"10.1016\/j.ejps.2025.107398_bib0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijpharm.2019.01.051","article-title":"Micelle-solubilized axitinib for ocular administration in anti-neovascularization","volume":"560","author":"Shi","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107398_bib0056","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.exer.2006.08.018","article-title":"Age-related changes in sympathetic neurotransmission in rat retina and choroid","volume":"84","author":"Smith","year":"2007","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejps.2025.107398_bib0057","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.943915","article-title":"Application and mechanism of anti-VEGF drugs in age-related macular degeneration","volume":"10","author":"Song","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ejps.2025.107398_bib0058","first-page":"394","article-title":"Feasibility of drug delivery to the eye's posterior segment by topical instillation of PLGA nanoparticles","volume":"12","author":"Tahara","year":"2017","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107398_bib0059","article-title":"Ocular nanomedicine","volume":"9","author":"Tang","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejps.2025.107398_bib0060","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3390\/pharmaceutics14061253","article-title":"Evaluation of topical and subconjunctival injection of hyaluronic acid-coated nanoparticles for drug delivery to posterior eye","volume":"14","author":"Tsai","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107398_bib0061","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.3390\/ijms19092830","article-title":"Ocular drug delivery: role of degradable polymeric nanocarriers for ophthalmic application","volume":"19","author":"Tsai","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2025.107398_bib0062","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10633-009-9191-8","article-title":"Dimethyl sulphoxide dose\u2013response on rat retinal function","volume":"119","author":"Tsai","year":"2009","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.ejps.2025.107398_bib0063","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.3390\/ijms24032753","article-title":"High-capacity mesoporous silica nanocarriers of siRNA for applications in retinal delivery","volume":"24","author":"Ultimo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2025.107398_bib0064","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212368","article-title":"Nanotechnology for topical drug delivery to the anterior segment of the eye","volume":"22","author":"Vaneev","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2025.107398_bib0065","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/pharmaceutics12030269","article-title":"Drug delivery to the posterior segment of the eye: biopharmaceutic and pharmacokinetic considerations","volume":"12","author":"Varela-Fern\u00e1ndez","year":"2020","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejps.2025.107398_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114721","article-title":"Nano-based eye drop: topical and noninvasive therapy for ocular diseases","volume":"194","author":"Wang","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2025.107398_bib0067","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.ejps.2025.107398_bib0068","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.apsb.2018.01.007","article-title":"Mesoporous silica nanoparticles for drug and gene delivery","volume":"8","author":"Zhou","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejps.2025.107398_bib0069","article-title":"Lipid-based nanocarriers mediated axitinib retinal delivery after topical instillation: formulations setting up and in vivo evidence","volume":"100","author":"Zingale","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725003951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725003951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T02:37:51Z","timestamp":1773887871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725003951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":69,"alternative-id":["S0928098725003951"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107398","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual-functionalized mesoporous silica nanoparticles for topical axitinib delivery to the posterior eye segment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107398","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107398"}}